Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Arrhythmias and sudden death

Original research

Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation

Online download statistics by month:

Online download statistics by month: December 2020 to March 2024

	Abstract	Full	Pdf
Dec 2020	4106	410	341
Jan 2021	953	105	82
Feb 2021	711	78	82
Mar 2021	637	71	85
Apr 2021	780	57	59
May 2021	294	69	65
Jun 2021	60	45	47
Jul 2021	53	36	43
Aug 2021	139	121	100
Sep 2021	119	94	90
Oct 2021	764	60	73
Nov 2021	829	83	85
Dec 2021	503	66	45
Jan 2022	525	57	58
Feb 2022	471	51	31
Mar 2022	820	66	55
Apr 2022	600	45	40
May 2022	574	50	47
Jun 2022	632	58	51
Jul 2022	514	46	34
Aug 2022	295	28	18
Sep 2022	476	55	46
Oct 2022	422	50	31
Nov 2022	331	45	28
Dec 2022	285	18	15
Jan 2023	314	27	28
Feb 2023	368	40	25
Mar 2023	451	33	27
Apr 2023	287	29	22
May 2023	326	23	27
Jun 2023	259	24	23
Jul 2023	252	16	11
Aug 2023	180	20	12
Sep 2023	279	40	27
Oct 2023	331	32	15
Nov 2023	306	28	17
Dec 2023	170	16	11
Jan 2024	131	14	9
Feb 2024	137	13	6
Mar 2024	189	15	7
Total	19873	2234	1918